I am proud to announce, on behalf of the DAHANCA group, that our national phase IV study on cancer of unknown primary in the head and neck is out! 📣📣. We thoroughly evaluated the current Danish management strategy of this complicated disease.

A pleasure for me to participate in #ECHNO2025 in Amsterdam, gathering experts in head and neck cancer. Thank you for interesting discussions after my talk in the DAHANCA session on TBM by TORS in HNSCCUP. Also, congratulations to @SomiahSiddiq for a brilliant review on the topic

Our national study presenting the largest cohort of patients with head and neck cancer of unknown primary (HNSCCUP) undergoing tongue base mucosectomy after guideline based work-up is now published! Please take a look.

Welcoming everyone with an interest in head and neck cancer of unknown primary to participate in my PhD defence in Aarhus, on the 31st of May.

🗞️Publication alert! ✍️ . I am happy to share that our dose plan study comparing protons vs. photons in the primary and recurrent setting of head and neck SCC of unknown primary is out.

Thrilled by Trine Tramm's presentation on hos immunity and tumour microenvironment as a predictor of RT. Trine has excellent communication skills and her research is outstanding! .#ESTRO23

Yesterday was a big! On behalf of the DAHANCA group, I had the great honor to present the results of our point of origin based pattern of failure study on IMRT treated patients with cancer of unknown primary in the head and neck (HNSCC CUP) at ESTRO .@ESTRO_RT @oncaarhus

RT @oncaarhus: #estro2022 .#CancerResearch .@AUHdk

RT @oncaarhus: 📣 Nyt tiltag på @oncaarhus !.Nu er den her - prisen vi alle har ventet på! Vi er stolte af at kunne præsentere den spritnye….